Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy: Results from a Longitudinal Study.
Hoffmann C, Ringbaek T, Eckstein A, Deya W, Santiago A, Heintz M, Lübcke W, Indenkämpen F, Sauerwein W, Flühs A, Le Guin C, Huettmann A, von Tresckow J, Göricke S, Deuschl C, Moliavi S, Poettgen C, Gauler T, Guberina N, Johansson P, Bechrakis N, Stuschke M, Guberina M. Hoffmann C, et al. Among authors: guberina n. Cancers (Basel). 2023 Nov 15;15(22):5433. doi: 10.3390/cancers15225433. Cancers (Basel). 2023. PMID: 38001692 Free PMC article.
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy: Results from a longitudinal study.
Hoffmann C, Rating P, Bechrakis N, Eckstein A, Sokolenko E, Jabbarli L, Westekemper H, Mohr C, Schmeling C, Huettmann A, von Tresckow J, Göricke S, Deuschl C, Johansson P, Poettgen C, Gauler T, Guberina N, Moliavi S, Stuschke M, Guberina M. Hoffmann C, et al. Among authors: guberina n, guberina m. Hematol Oncol. 2022 Dec;40(5):922-929. doi: 10.1002/hon.3053. Epub 2022 Aug 7. Hematol Oncol. 2022. PMID: 35857866
Feasibility, Method and Early Outcome of Image-Guided Volumetric Modulated Arc Radiosurgery Followed by Resection for AJCC Stage IIA-IIIB High-Risk Large Intraocular Melanoma.
Guberina M, Sokolenko E, Guberina N, Dalbah S, Pöttgen C, Lübcke W, Indenkämpen F, Lachmuth M, Flühs D, Chen Y, Hoffmann C, Deuschl C, Jabbarli L, Fiorentzis M, Foerster A, Rating P, Ebenau M, Grunewald T, Bechrakis N, Stuschke M. Guberina M, et al. Among authors: guberina n. Cancers (Basel). 2022 Sep 28;14(19):4729. doi: 10.3390/cancers14194729. Cancers (Basel). 2022. PMID: 36230660 Free PMC article.
Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors.
Jabbarli L, Guberina M, Biewald E, Flühs D, Guberina N, Le Guin CHD, Sauerwein W, Bornfeld N, Stuschke M, Bechrakis NE. Jabbarli L, et al. Among authors: guberina n, guberina m. Clin Exp Ophthalmol. 2021 May;49(4):357-367. doi: 10.1111/ceo.13928. Epub 2021 May 4. Clin Exp Ophthalmol. 2021. PMID: 33866652
Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin.
Guberina M, Santiago Garcia A, Khouya A, Pöttgen C, Holubyev K, Ringbaek TP, Lachmuth M, Alberti Y, Hoffmann C, Hlouschek J, Gauler T, Lübcke W, Indenkämpen F, Stuschke M, Guberina N. Guberina M, et al. Among authors: guberina n. JAMA Netw Open. 2023 Mar 1;6(3):e234066. doi: 10.1001/jamanetworkopen.2023.4066. JAMA Netw Open. 2023. PMID: 36947038 Free PMC article.
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics.
Hoffmann C, Mohr C, Johansson P, Eckstein A, Huettmann A, von Tresckow J, Göricke S, Deuschl C, Poettgen C, Gauler T, Guberina N, Moliavi S, Bechrakis N, Stuschke M, Guberina M. Hoffmann C, et al. Among authors: guberina n, guberina m. Sci Rep. 2023 Mar 23;13(1):4792. doi: 10.1038/s41598-023-31941-w. Sci Rep. 2023. PMID: 36959374 Free PMC article.
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis.
Guberina N, Padeberg F, Pöttgen C, Guberina M, Lazaridis L, Jabbarli R, Deuschl C, Herrmann K, Blau T, Wrede KH, Keyvani K, Scheffler B, Hense J, Layer JP, Glas M, Sure U, Stuschke M. Guberina N, et al. Cancers (Basel). 2023 May 30;15(11):2982. doi: 10.3390/cancers15112982. Cancers (Basel). 2023. PMID: 37296942 Free PMC article.
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry.
Pöttgen C, Hoffmann C, Gauler T, Guberina M, Guberina N, Ringbaek T, Santiago Garcia A, Krafft U, Hadaschik B, Khouya A, Stuschke M. Pöttgen C, et al. Among authors: guberina n. Cancers (Basel). 2023 Oct 11;15(20):4933. doi: 10.3390/cancers15204933. Cancers (Basel). 2023. PMID: 37894299 Free PMC article.
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.
Guberina N, Pöttgen C, Schuler M, Guberina M, Stamatis G, Plönes T, Metzenmacher M, Theegarten D, Gauler T, Darwiche K, Aigner C, Eberhardt WEE, Stuschke M. Guberina N, et al. Among authors: guberina m. Radiat Oncol. 2022 Jul 16;17(1):126. doi: 10.1186/s13014-022-02080-9. Radiat Oncol. 2022. PMID: 35842712 Free PMC article.
78 results